Ligand Pharmaceuticals (LGND)
Ligand Pharmaceuticals Max Pain By Strike
LGND trades at $168.96, 9.0% above the near-term max pain of $155 expiring Sep 19, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($95-$155), signaling increased put positioning or downside protection. High dispersion in max pain levels suggests competing forces and potential volatility.
Ligand Pharmaceuticals Max Pain By Expiry
Max pain for LGND shows a downward trend from 155 to 95, indicating bearish sentiment or hedging activity. The 47% spread signals divergent expectations across timeframes. Most levels below 168.96 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 155 | -13.96 (-8.26%) |
| Oct 17, 2025 | 95 | -73.96 (-43.77%) |
| Nov 21, 2025 | 125 | -43.96 (-26.02%) |
| Feb 20, 2026 | 135 | -33.96 (-20.10%) |